Table 2.
A variety of electrospinning solutions based on hyaluronan with additional polymers.
| Mw(HA), kDa | AdP (Mw), kDa |
CHA, w/v% |
CAdP, w/v% |
Solvents (v/v or w/w) |
Additives | References |
|---|---|---|---|---|---|---|
| 8.7 | PEO (900) | Σ 8.0 | AA/DW (50:50) | - | [64] | |
| 600–1100 | PEO (200) | 0.1–0.3 | 12.0 | DW | Kanamycin (1.0 % w/v) |
[65] |
| 680 | CL (Mw n.r.) |
Σ 10.0 (WR 95/5, 80/20) |
NaOH/DMF (4/1) |
NaCl (salt particulates) EDC |
[66] | |
| HA-DTPH (158) |
PEO (900) | 2.5 | 2.5 | DMEM | PEGDA | [70] |
| 57 | PVA (130) | Σ 6.0 | DW | HPβCD EDC, NHS |
[72] | |
| 601–850 | CL (Mw n.r.) |
Σ 7.5 (WR 95/5) |
NaOH/DMF (4/1) |
Au nanoparticles EDC |
[67] | |
| 1000– 2000 |
PEO (900) | 0.2 | 5.0 | DW | - | [73] |
| 1000 | CS (200) |
1.0 | 7.0 |
DW/FA (25/75) DW/FA (20/80) |
- | [74] |
| 54.0 | PEO (Mw n.r.) |
4.0 | 0.6 | DW | - | [76] |
| HA-DTPH (158) | PEO (900) | 2.0 | 0.5–2.0 | DMEM | PEGDA | [78] |
| Nor-HA (Mw n.r.) |
PEO (Mw n.r.) |
3.25 | 2.75 | Albumin, UV-initiator, DTT | [79] | |
Abbreviated terms: AA—acetic acid; AdP—additional polymer; CL—collagen; CS—chitosan; DMEM—Dulbecco’s Modified Eagle’s Medium; DMF—dimethyl formamide; DMSO—dimethyl sulfoxide; DTT—dithiothreitol; DW—distillated (deionized) water; EDC—1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; FA—formic acid; GE—gelatin; HA—hyaluronan/hyaluronic acid; HA-DTPH—3,3′-dithiobis(propanoic dihydrazide)-modified hyaluronic acid; HPβCD—(2-Hydroxypropyl)-β-cyclodextrin; n.r.—not reported; NHS—N-Hydroxysuccinimide; Nor-HA—norbornene-functionalized hyaluronic acid; PEGDA—Poly(ethylene glycol) diacrylate; PEO—polyethylene oxide; PVA—polyvinyl alcohol; WR—weight ratio.